BA vs PFE: Which Is the Better Buy?
Side-by-side comparison of The Boeing Company and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
The Boeing Company · Industrials
$231.28
+45.0% upside to fair value
Grade C
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
BA has more upside to fair value
(+45.0%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BA |
PFE |
| Current Price |
$231.28 |
$26.33 |
| Fair Value Estimate |
$335.36 |
$33.85 |
| Upside to Fair Value |
+45.0%
|
+28.6%
|
| Market Cap |
$181.8B |
$149.8B |
| Forward P/E |
83.4x
|
19.3x
|
| EV / EBITDA |
30.8x
|
12.9x
|
| Price / Sales |
2.0x
|
2.4x
|
| Price / FCF |
776.7x
|
16.5x
|
| Revenue Growth YoY |
+14.0%
|
-1.2%
|
| Gross Margin |
4.8%
|
70.3%
|
| Operating Margin |
-5.9%
|
24.7%
|
| Return on Equity |
-8723.1%
|
8.7%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.13%
|
6.06%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
The Boeing Company is a leading global aerospace and defense firm operating across commercial airplanes, defense, space and security, and global services segments. Despite a challenging operating margin of negative 5.9% and a high trailing P/E of 83.43, Boeing is currently fairly valued with a fair value estimate of $422.56, implying an 82.7% upside from the current price of $231.28. The company …
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
BA |
PFE |
| Zone Low |
$251.52 |
$25.39 |
| Zone High |
$285.06 |
$28.77 |
| In Buy Zone? |
Yes
|
Yes
|